ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Lung Cancer trials near San Francisco, CA, USA:

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...

Enrolling
Metastatic Non-small Cell Lung Cancer
Drug: Osimertinib
Drug: Carboplatin

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

San Francisco, California, United States and 16 other locations

with osimertinib in treating patients with EGFR-mutated stage IV lung cancer. Alisertib may stop the growth of tumor cells ...

Enrolling
Lung Cancer Metastatic
EGFR Gene Mutation
Drug: Osimertinib
Drug: Alisertib

Phase 1

Collin Blakely

San Francisco, California, United States

Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before surgery. Osimertinib may stop the growth of tumor...

Active, not recruiting
Stage IA Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer
Procedure: Therapeutic Conventional Surgery
Drug: Osimertinib

Phase 2

University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States and 2 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

San Francisco, California, United States and 30 other locations

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...

Active, not recruiting
Non-small Cell Lung Cancer (NSCLC)
Cancer
Drug: Cofetuzumab Pelidotin

Phase 1

AbbVie
AbbVie

Stanford, California, United States and 25 other locations

The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON...

Enrolling
Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
Non-Small Cell Lung Cancer, NSCLC
Drug: Pembrolizumab
Drug: RMC-6291

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

San Francisco, California, United States and 40 other locations

, early-stage non-small cell lung cancer....

Enrolling
Non-small Cell Lung Cancer
Drug: Dato-DXd
Drug: Durvalumab

Phase 2

AstraZeneca
AstraZeneca

Oakland, California, United States and 94 other locations

New

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...

Begins enrollment this month
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

San Francisco, California, United States and 219 other locations

with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or hormone receptor positive (HR+), human epide....

Active, not recruiting
Breast Cancer
Non Small Cell Lung Cancer
Drug: Abemaciclib
Drug: Anastrozole

Phase 1

Lilly
Lilly

San Francisco, California, United States and 23 other locations

A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer i...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: MEDI4736

Phase 2

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 137 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems